Cinuperone

Cinuperone

SCHEMBL31395265

O=C(CCCN1CCN(c2cc3ccccc3cn2)CC1)c1ccc(F)cc1

nearest known ligand 0.70

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR1A P08908 8/20 0.70
DRD2 P14416 8/20 0.70
DRD4 P21917 8/20 0.70
HTR2A P28223 8/20 0.70
DRD3 P35462 8/20 0.70
HTR2C P28335 7/20 0.70
HTR7 P34969 6/20 0.70
TMEM97 Q5BJF2 5/20 0.70
SIGMAR1 Q99720 5/20 0.70
LMNA P02545 1/20 0.70
CYP1A2 P05177 1/20 0.70
CYP3A4 P08684 1/20 0.70
CYP2D6 P10635 1/20 0.70
CYP2C9 P11712 1/20 0.70
CYP2C19 P33261 1/20 0.70
SMN1; SMN2 Q16637 1/20 0.70
HRH1 P35367 2/20 0.64
ADRA2C P18825 1/20 0.64
SLC6A4 P31645 1/20 0.63
ALDH1A1 P00352 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Cinuperone SCHEMBL678891 1.00 HTR1A (0.70) HTR1ADRD2DRD4HTR2ADRD3
SCHEMBL10834325 0.92 DRD2 (0.67) HTR1ADRD2DRD4HTR2ADRD3
SCHEMBL10832658 0.91 HTR1A (0.57) HTR1ADRD2DRD4HTR2ADRD3
SCHEMBL10833658 0.89 HTR1A (0.55) HTR1ADRD2DRD4HTR2ADRD3
SCHEMBL10834159 0.88 DRD2 (0.74) HTR1ADRD2DRD4HTR2ADRD3
SCHEMBL10833626 0.87 HTR1A (0.53) HTR1ADRD2DRD4HTR2ADRD3
SCHEMBL10833664 0.86 DRD2 (0.61) HTR1ADRD2DRD4HTR2ADRD3
SCHEMBL10833527 0.85 HTR2A (0.52) HTR1ADRD2DRD4HTR2ADRD3
SCHEMBL10833345 0.85 DRD2 (0.59) HTR1ADRD2DRD4HTR2ADRD3
SCHEMBL10787321 0.84 DRD2 (0.69) HTR1ADRD2DRD4HTR2ADRD3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025031979-A1 USE OF RIMCAZOLE TO TREAT CANCER KYREXA LTD (GB) 2025-02-13 WO disclosed